Your browser doesn't support javascript.
loading
Inborn errors of enzymes in glutamate metabolism.
Rumping, Lynne; Vringer, Esmee; Houwen, Roderick H J; van Hasselt, Peter M; Jans, Judith J M; Verhoeven-Duif, Nanda M.
Afiliación
  • Rumping L; Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Vringer E; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Houwen RHJ; Department of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • van Hasselt PM; Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Jans JJM; Department of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Verhoeven-Duif NM; Department of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
J Inherit Metab Dis ; 43(2): 200-215, 2020 03.
Article en En | MEDLINE | ID: mdl-31603991
Glutamate is involved in a variety of metabolic pathways. We reviewed the literature on genetic defects of enzymes that directly metabolise glutamate, leading to inborn errors of glutamate metabolism. Seventeen genetic defects of glutamate metabolising enzymes have been reported, of which three were only recently identified. These 17 defects affect the inter-conversion of glutamine and glutamate, amino acid metabolism, ammonia detoxification, and glutathione metabolism. We provide an overview of the clinical and biochemical phenotypes of these rare defects in an effort to ease their recognition. By categorising these by biochemical pathway, we aim to create insight into the contributing role of deviant glutamate and glutamine levels to the pathophysiology. For those disorders involving the inter-conversion of glutamine and glutamate, these deviant levels are postulated to play a pivotal pathophysiologic role. For the other IEM however-with the exception of urea cycle defects-abnormal glutamate and glutamine concentrations were rarely reported. To create insight into the clinical consequences of disturbed glutamate metabolism-rather than individual glutamate and glutamine levels-the prevalence of phenotypic abnormalities within the 17 IEM was compared to their prevalence within all Mendelian disorders and subsequently all disorders with metabolic abnormalities notated in the Human Phenotype Ontology (HPO) database. For this, a hierarchical database of all phenotypic abnormalities of the 17 defects in glutamate metabolism based on HPO was created. A neurologic phenotypic spectrum of developmental delay, ataxia, seizures, and hypotonia are common in the inborn errors of enzymes in glutamate metabolism. Additionally, ophthalmologic and skin abnormalities are often present, suggesting that disturbed glutamate homeostasis affects tissues of ectodermal origin: brain, eye, and skin. Reporting glutamate and glutamine concentrations in patients with inborn errors of glutamate metabolism would provide additional insight into the pathophysiology.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Errores Innatos del Metabolismo de los Aminoácidos / Glutamatos / Glutamina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Inherit Metab Dis Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Errores Innatos del Metabolismo de los Aminoácidos / Glutamatos / Glutamina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Inherit Metab Dis Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
...